Lixte Biotechnology News - LIXT

Company Name	Stock Ticker Symbol	Market	Type
Lixte Biotechnology Holdings Inc	LIXT	NASDAQ	Common Stock

	Price Change	Change Percent	Stock Price	Last Traded
	0.00	0.00%	3.28	07:00:06

Open Price	Low Price	High Price	Close Price	Prev Close
				3.28

more quote information »

Recent News

Date	Time	Source	Heading
4/25/2024	8:52	IHNW	FeaturedCannabix's Breath Logix Alcohol Device Delivers Positive Impact to Private Monitoring Agency in Montana, USA
4/24/2024	15:25	APS	Mixed Shelf Filing Gives Micro Cap Delayed Boost
3/27/2024	15:35	APS	Biotech Steals The Show Following Pre-Clinical Data..
3/27/2024	08:30	GLOBE	NEW SCIENTIFIC PUBLICATION SHOWS LB-100, LIXTE’S LEAD..
3/21/2024	08:30	GLOBE	LIXTE Provides Update on Progress with LB-100 as a PP2A..
2/27/2024	16:59	EDGAR2	Form 8-K - Current report
2/27/2024	08:30	GLOBE	Professor René Bernards to Present New Pre-Clinical Data on..
2/26/2024	10:48	EDGAR2	Form 8-K - Current report
2/26/2024	08:30	GLOBE	LIXTE Biotechnology Enters into Exclusive Immune Oncology..
1/29/2024	08:30	GLOBE	First Patient Dosed with LIXTE’s LB-100 and GSK’s..
11/28/2023	17:21	EDGAR2	Form 8-K - Current report
11/13/2023	14:28	EDGAR2	Form 8-K - Current report
11/13/2023	08:30	GLOBE	LIXTE Biotechnology Provides Update on Clinical Progress and..
11/09/2023	17:16	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
10/17/2023	17:27	EDGAR2	Form 8-K - Current report
10/16/2023	14:51	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
10/16/2023	08:30	GLOBE	LIXTE, Netherlands Cancer Institute, and Oncode Institute to..
10/10/2023	15:55	EDGAR2	Form DEFA14A - Additional definitive proxy soliciting..
10/10/2023	15:47	EDGAR2	Form DEF 14A - Other definitive proxy statements
10/09/2023	08:30	GLOBE	LIXTE Biotechnology Holdings Announces the Passing of its..
10/05/2023	20:39	EDGAR2	Form 4/A - Statement of changes in beneficial ownership of..
10/05/2023	20:36	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
10/04/2023	18:10	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
9/29/2023	16:05	EDGAR2	Form PRE 14A - Other preliminary proxy statements
9/27/2023	06:15	EDGAR2	Form 8-K - Current report
9/27/2023	06:05	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
9/26/2023	08:30	GLOBE	LIXTE Appoints Bas van der Baan as President and Chief..
9/20/2023	11:20	EDGAR2	Form 8-K - Current report
9/20/2023	08:30	GLOBE	LIXTE Biotechnology Announces a Supported Collaborative..
8/11/2023	16:20	EDGAR2	Form S-3 - Registration statement under Securities Act of..
8/09/2023	08:30	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
7/21/2023	16:05	EDGAR2	Form 8-K - Current report
7/20/2023	16:25	EDGAR2	Form 424B5 - Prospectus [Rule 424(b)(5)]
7/20/2023	16:05	GLOBE	LIXTE Biotechnology Announces Closing of $3.5 Million..
7/20/2023	11:45	EDGAR2	Form 8-K - Current report
7/18/2023	08:00	GLOBE	LIXTE Biotechnology Announces Pricing of $3.5 Million..
7/17/2023	08:30	GLOBE	Preclinical Results of LIXTE Biotechnology’s Collaboration..
7/07/2023	14:52	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
7/07/2023	10:58	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
7/07/2023	10:57	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
7/07/2023	10:55	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
6/23/2023	08:30	GLOBE	LIXTE Biotechnology Holdings, Inc. Regains Compliance with..
6/07/2023	08:30	GLOBE	LIXTE Biotechnology and the Spanish Sarcoma Group Enroll..
6/02/2023	12:30	GLOBE	LIXTE Biotechnology Holdings, Inc. Announces 1-for-10..
5/30/2023	08:30	GLOBE	Recently Published Independent Research Reveals New..